Envestnet Asset Management Inc Charles River Laboratories International, Inc. Transaction History

Envestnet Asset Management Inc

  • $326 Billion
  • Q2 2025

A detailed history of Envestnet Asset Management Inc transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Envestnet Asset Management Inc holds 85,521 shares of CRL stock, worth $15 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
85,521
Previous 221,261 61.35%
Holding current value
$15 Million
Previous $33.3 Million 61.04%
% of portfolio
0.0%
Previous 0.01%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Jul 31, 2025
SELL
$99.75 - $151.89 $13.5 Million - $20.6 Million
-135,740 Reduced 61.35%
85,521 $13 Million
Q1 2025

Apr 29, 2025
SELL
$150.52 - $190.14 $3.46 Million - $4.37 Million
-22,973 Reduced 9.41%
221,261 $33.3 Million
Q4 2024

Feb 12, 2025
SELL
$178.58 - $220.69 $7.39 Million - $9.13 Million
-41,369 Reduced 14.48%
244,234 $45.1 Million
Q3 2024

Nov 06, 2024
SELL
$187.96 - $245.29 $6.31 Million - $8.24 Million
-33,574 Reduced 10.52%
285,603 $56.3 Million
Q2 2024

Aug 08, 2024
BUY
$206.39 - $268.73 $2.38 Million - $3.09 Million
11,514 Added 3.74%
319,177 $65.9 Million
Q1 2024

May 13, 2024
BUY
$203.52 - $273.43 $7.96 Million - $10.7 Million
39,097 Added 14.56%
307,663 $83.4 Million
Q4 2023

Feb 13, 2024
SELL
$164.52 - $238.84 $41,130 - $59,710
-250 Reduced 0.09%
268,566 $63.5 Million
Q3 2023

Nov 13, 2023
BUY
$194.44 - $217.61 $17.3 Million - $19.3 Million
88,862 Added 49.38%
268,816 $52.7 Million
Q2 2023

Aug 04, 2023
BUY
$183.71 - $210.25 $2.52 Million - $2.89 Million
13,741 Added 8.27%
179,954 $37.8 Million
Q1 2023

May 11, 2023
BUY
$191.89 - $259.92 $1.12 Million - $1.52 Million
5,850 Added 3.65%
166,213 $33.5 Million
Q4 2022

Feb 07, 2023
SELL
$197.11 - $250.07 $681,212 - $864,241
-3,456 Reduced 2.11%
160,363 $34.9 Million
Q3 2022

Nov 10, 2022
BUY
$182.44 - $250.54 $1.13 Million - $1.56 Million
6,220 Added 3.95%
163,819 $32.2 Million
Q2 2022

Aug 03, 2022
SELL
$204.13 - $302.4 $776,714 - $1.15 Million
-3,805 Reduced 2.36%
157,599 $33.7 Million
Q1 2022

May 04, 2022
BUY
$255.51 - $362.11 $5.28 Million - $7.48 Million
20,665 Added 14.68%
161,404 $45.8 Million
Q4 2021

Feb 04, 2022
BUY
$351.38 - $448.68 $4.56 Million - $5.82 Million
12,972 Added 10.15%
140,739 $53 Million
Q3 2021

Oct 07, 2021
BUY
$372.64 - $458.3 $3.44 Million - $4.23 Million
9,226 Added 7.78%
127,767 $52.7 Million
Q2 2021

Aug 04, 2021
SELL
$294.17 - $371.65 $5.19 Million - $6.56 Million
-17,659 Reduced 12.97%
118,541 $43.9 Million
Q1 2021

May 04, 2021
BUY
$249.67 - $299.48 $3.9 Million - $4.68 Million
15,632 Added 12.97%
136,200 $39.5 Million
Q4 2020

Feb 02, 2021
BUY
$222.0 - $252.62 $1.46 Million - $1.67 Million
6,597 Added 5.79%
120,568 $30.1 Million
Q3 2020

Oct 09, 2020
BUY
$175.56 - $226.45 $841,810 - $1.09 Million
4,795 Added 4.39%
113,971 $25.8 Million
Q2 2020

Jul 08, 2020
BUY
$118.84 - $189.72 $370,899 - $592,116
3,121 Added 2.94%
109,176 $19 Million
Q1 2020

Apr 23, 2020
BUY
$98.9 - $178.34 $3.46 Million - $6.24 Million
35,003 Added 49.26%
106,055 $13.4 Million
Q4 2019

Feb 11, 2020
BUY
$126.05 - $152.76 $39,453 - $47,813
313 Added 0.44%
71,052 $10.9 Million
Q3 2019

Oct 17, 2019
BUY
$125.07 - $143.67 $149,583 - $171,829
1,196 Added 1.72%
70,739 $9.36 Million
Q2 2019

Aug 02, 2019
BUY
$123.4 - $148.55 $1.47 Million - $1.77 Million
11,932 Added 20.71%
69,543 $9.87 Million
Q1 2019

May 10, 2019
BUY
$104.82 - $146.73 $564,770 - $790,581
5,388 Added 10.32%
57,611 $8.37 Million
Q4 2018

Feb 13, 2019
BUY
$105.09 - $137.23 $4.75 Million - $6.2 Million
45,188 Added 642.33%
52,223 $5.91 Million
Q3 2018

Nov 14, 2018
SELL
$112.11 - $134.54 $329,827 - $395,816
-2,942 Reduced 29.49%
7,035 $946,000
Q2 2018

Aug 10, 2018
BUY
$102.37 - $117.25 $809,951 - $927,682
7,912 Added 383.15%
9,977 $1.12 Million
Q1 2018

May 09, 2018
SELL
$98.19 - $115.2 $1.15 Million - $1.34 Million
-11,664 Reduced 84.96%
2,065 $220,000
Q4 2017

Feb 20, 2018
SELL
$100.43 - $118.09 $15,767 - $18,540
-157 Reduced 1.13%
13,729 $1.5 Million
Q3 2017

Nov 13, 2017
BUY
$96.72 - $109.26 $1.21 Million - $1.37 Million
12,497 Added 899.71%
13,886 $1.5 Million
Q2 2017

Aug 14, 2017
BUY
N/A
1,389
1,389 $142,000

Others Institutions Holding CRL

# of Institutions
619
Shares Held
52.6M
Call Options Held
1.42M
Put Options Held
1.42M
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $8.9B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Envestnet Asset Management Inc Portfolio

Follow Envestnet Asset Management Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Envestnet Asset Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Envestnet Asset Management Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email